Developing Novel Biomarkers & Optimum Endpoints Beyond 90-Day Mortality to Improve Clinical Progress in AKI

Time: 12:30 pm
day: Seminar Day

Details:

  • Implementing GFR, Albuminuria, and patient-reported outcomes as
    endpoints
  • Should we move away from 90-day mortality outcomes?
  • Reflecting on clinical setbacks: considering alternative outcomes to
    monitor efficacy more effectively

Speakers: